Thermo Fisher Scientific Inc.
TMO· NYSE
Source filing unavailable
| Metric | Q4 2018 | Q4 2017 | Q4 2016 | Q4 2015 |
|---|---|---|---|---|
| Revenue | $6.51B | $6.05B | $4.95B | $4.65B |
| EPS Diluted | $2.22 | $1.30 | $1.59 | $1.50 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Thermo Fisher Scientific Inc. · CIK 97745 · Engraved from SEC EDGAR